Koers Harvard Bioscience, Inc.
Aandelen
HBIO
US4169061052
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,56 USD | -3,52% | -10,33% | -33,46% |
Omzet 2024 * | 114 mln. 106 mln. | Omzet 2025 * | 126 mln. 117 mln. | Marktkapitalisatie | 155 mln. 144 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 3 mln. 2,8 mln. | EV/omzet 2024 * | 1,36 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,23 x |
K/w-verhouding 2024 * |
-712
x | K/w-verhouding 2025 * |
47,5
x | Werknemers | 404 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,72% |
Recentste transcriptie over Harvard Bioscience, Inc.
1 dag | -3,52% | ||
1 week | -10,33% | ||
Lopende maand | -16,04% | ||
1 maand | -13,80% | ||
3 maanden | -22,78% | ||
6 maanden | -17,40% | ||
Lopend jaar | -33,46% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 28-04-15 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 01-05-22 |
David Balcom
COO | Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 28-04-15 |
Alan Edrick
BRD | Director/Board Member | 56 | 03-09-19 |
Bertrand Loy
BRD | Director/Board Member | 58 | 06-11-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.37% | 4 M€ | -5,15% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 3,56 | -3,52% | 65 306 |
24-04-24 | 3,69 | -0,81% | 63 556 |
23-04-24 | 3,72 | +0,54% | 92 096 |
22-04-24 | 3,7 | 0,00% | 90 516 |
19-04-24 | 3,7 | -6,80% | 87 259 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,46% | 160 mln. | |
+7,71% | 220 mld. | |
+6,25% | 185 mld. | |
+10,60% | 133 mld. | |
+26,73% | 107 mld. | |
-0,57% | 62,91 mld. | |
+15,42% | 53,34 mld. | |
-1,89% | 47,71 mld. | |
-1,91% | 40,29 mld. | |
+11,16% | 39,57 mld. |